Company news

Futura Medical plc news in 2023

Futura Medical plc's news releases, calls and decks from 2023, newest first.

View company

Futura expands partnership with M8 Pharmaceuticals

November 7, 2023

Eroxon Awarded “New Product of the Year” by Boots

November 2, 2023

Block Listing Application and Total Voting Rights

October 31, 2023

Eroxon® Granted Marketing Authorisation in Mexico

October 25, 2023

Eroxon Launches in the United Arab Emirates

October 19, 2023

Directors’/PDMR Dealing and Grant of Options

October 10, 2023

European Patent Granted for MED3000 until 2040

October 2, 2023

Futura Medical - Interim Results 2023

September 18, 2023

Futura Medical - Notice of Interim Results

August 18, 2023

MED3000 Commercialisation Approval in Saudi Arabia

August 9, 2023

Futura Medical - Total Voting Rights

July 31, 2023

Futura Medical "absolutely delighted" with US commercialisation agreement

July 19, 2023

Board Change

July 18, 2023

Futura/Haleon Enter US Commercialisation Agreement

July 17, 2023

Recording of Investor Seminar

June 23, 2023

Futura Medical Annual General Meeting Results

June 22, 2023

Correction - TR-1: Notification of major holdings

June 19, 2023

Exercise of Warrants

June 12, 2023

Futura Medical Announces Investor Seminar

June 8, 2023

MED3000, Eroxon® UK Launch

April 18, 2023

Directors' / PDMR Dealing and Grant of Options

April 6, 2023

Full Year Results ended 31 December 2022

April 5, 2023

Update on MED3000 regulatory approval in the US

March 29, 2023

Notice of Preliminary Results 2022

March 27, 2023

MED3000 commercial and US regulatory update

March 14, 2023

MED3000 FM71 Presentation at ESSM Congress 2023

February 15, 2023

Block Listing Applications to AIM

February 1, 2023

Pre-launch of MED3000 ahead of H1 2023 launch

January 26, 2023

Futura Remuneration, Options & Total Voting Rights

January 12, 2023

Calls in 2023